Indaptus Therapeutics Inc.
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 21 institutions reported holding Indaptus Therapeutics Inc. in their 13F filings, up 4 from Q1 2024. 5 opened new positions and 1 sold out. The largest holders were Vanguard Group Inc. ($543K), Investment House LLC ($217K) and Geode Capital Management, LLC ($126K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Indaptus Therapeutics Inc.
- CUSIP
- 45339J105
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $48K |
| Exits | 1 | $32K |
All 13F filers, Q1 2024 → Q2 2024: 27,724 shares bought and 15,577 shares sold, net +12,147 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Vanguard Group Inc. | 0.00% | No change | 256,265 | $543K |
| Investment House LLC | 0.01% | No change | 102,437 | $217K |
| Geode Capital Management, LLC | 0.00% | Add +8.3% | 59,309 | $126K |
| Pine Valley Investments Ltd Liability Co | 0.01% | Reduce -0.1% | 44,085 | $93K |
| Strategy Asset Managers LLC | 0.02% | No change | 45,336 | $87K |
| Renaissance Technologies | 0.00% | Add +1.9% | 26,600 | $56K |
| Debussy Capital Management LP | 0.01% | No change | 24,000 | $51K |
| Citadel Advisors | 0.00% | New | 22,210 | $47K |
| State Street Corp. | 0.00% | No change | 13,073 | $28K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +0.9% | 4,102 | $9K |
| Morgan Stanley | 0.00% | No change | 884 | $2K |
| UBS Group AG | 0.00% | Reduce -64.3% | 692 | $1K |
| Bangor Savings Bank | 0.00% | No change | 400 | $848 |
| Beaird Harris Wealth Management, LLC | 0.00% | New | 300 | $636 |
| FMR LLC | 0.00% | New | 79 | $167 |
| Wells Fargo & Company | 0.00% | Reduce -39.0% | 64 | $136 |
| Bank of America Corp. | 0.00% | New | 42 | $89 |
| JPMorgan Chase & Co. | 0.00% | Add +7.1% | 15 | $32 |
| MassMutual Private Wealth & Trust, FSB | 0.00% | New | 14 | $30 |
| Group One Trading LLC | 0.00% | No change | 7 | $15 |
| Qube Research & Technologies Ltd | 0.00% | No change | 1 | $2 |
"% of holder's portfolio" is INDAPTUS THERAPEUTICS INC's weight in each manager's 13F, not the share of Indaptus Therapeutics Inc. the manager owns.